nasdaq:anip
|
401956
|
Mar 24th, 2024 12:00AM
|
ANI Pharmaceuticals, Inc.
|
14K
|
385.00
|
Open
|
|
Mar 23rd, 2024 11:52PM
|
Mar 23rd, 2024 11:52PM
|
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
|
Open
|
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
|
Open
|
500 Alexander Park
|
Princeton
|
New Jersey
|
US
|
08540
|
|
ANI Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:anip
|
401956
|
Mar 23rd, 2024 12:00AM
|
ANI Pharmaceuticals, Inc.
|
14K
|
385.00
|
Open
|
|
Mar 22nd, 2024 10:56PM
|
Mar 23rd, 2024 06:21PM
|
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
|
Open
|
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
|
Open
|
500 Alexander Park
|
Princeton
|
New Jersey
|
US
|
08540
|
|
ANI Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:anip
|
401956
|
Mar 22nd, 2024 12:00AM
|
ANI Pharmaceuticals, Inc.
|
14K
|
385.00
|
Open
|
|
Mar 21st, 2024 10:53PM
|
Mar 22nd, 2024 06:09PM
|
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
|
Open
|
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
|
Open
|
500 Alexander Park
|
Princeton
|
New Jersey
|
US
|
08540
|
|
ANI Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:anip
|
401956
|
Mar 21st, 2024 12:00AM
|
ANI Pharmaceuticals, Inc.
|
14K
|
385.00
|
Open
|
|
Mar 20th, 2024 10:51PM
|
Mar 21st, 2024 04:52PM
|
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
|
Open
|
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
|
Open
|
500 Alexander Park
|
Princeton
|
New Jersey
|
US
|
08540
|
|
ANI Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:anip
|
401956
|
Mar 20th, 2024 12:00AM
|
ANI Pharmaceuticals, Inc.
|
14K
|
384.00
|
Open
|
|
Mar 19th, 2024 11:09PM
|
Mar 20th, 2024 06:53PM
|
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
|
Open
|
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
|
Open
|
500 Alexander Park
|
Princeton
|
New Jersey
|
US
|
08540
|
|
ANI Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:anip
|
401956
|
Mar 19th, 2024 12:00AM
|
ANI Pharmaceuticals, Inc.
|
14K
|
384.00
|
Open
|
|
Mar 18th, 2024 10:49PM
|
Mar 19th, 2024 05:25PM
|
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
|
Open
|
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
|
Open
|
500 Alexander Park
|
Princeton
|
New Jersey
|
US
|
08540
|
|
ANI Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:anip
|
401956
|
Mar 18th, 2024 12:00AM
|
ANI Pharmaceuticals, Inc.
|
14K
|
384.00
|
Open
|
|
Mar 17th, 2024 11:02PM
|
Mar 18th, 2024 06:37PM
|
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
|
Open
|
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
|
Open
|
500 Alexander Park
|
Princeton
|
New Jersey
|
US
|
08540
|
|
ANI Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:anip
|
401956
|
Mar 17th, 2024 12:00AM
|
ANI Pharmaceuticals, Inc.
|
14K
|
385.00
|
Open
|
|
Mar 16th, 2024 11:45PM
|
Mar 16th, 2024 11:45PM
|
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
|
Open
|
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
|
Open
|
500 Alexander Park
|
Princeton
|
New Jersey
|
US
|
08540
|
|
ANI Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:anip
|
401956
|
Mar 16th, 2024 12:00AM
|
ANI Pharmaceuticals, Inc.
|
14K
|
385.00
|
Open
|
|
Mar 15th, 2024 10:36PM
|
Mar 16th, 2024 06:25PM
|
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
|
Open
|
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
|
Open
|
500 Alexander Park
|
Princeton
|
New Jersey
|
US
|
08540
|
|
ANI Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:anip
|
401956
|
Mar 15th, 2024 12:00AM
|
ANI Pharmaceuticals, Inc.
|
14K
|
385.00
|
Open
|
|
Mar 14th, 2024 11:39PM
|
Mar 15th, 2024 08:11AM
|
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
|
Open
|
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
|
Open
|
500 Alexander Park
|
Princeton
|
New Jersey
|
US
|
08540
|
|
ANI Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|